INDOMETHACIN vs INFLIXIMAB-DYYB: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
INDOMETHACIN vs INFLIXIMAB-DYYB: Safety Overview
| Metric | INDOMETHACIN | INFLIXIMAB-DYYB |
|---|---|---|
| Total FAERS Reports | 4,831 | 25,585 |
| Deaths Reported | 664 | 632 |
| Death Rate | 13.7% | 2.5% |
| Hospitalizations | 1,146 | 6,251 |
| Average Patient Age | 45.8 yrs | 48.5 yrs |
| % Female Patients | 79.1% | 54.0% |
| FDA Approval Date | Approved Prior to Jan 1, 1982 | N/A |
| Manufacturer | Zydus Lifesciences Limited | CELLTRION USA Inc. |
| Route | RECTAL | SUBCUTANEOUS |
| Marketing Status | Discontinued | Prescription |